Model
Edge
Alnylam Pharmaceuticals, Inc.
0001849458
Filing Type
4
Filing Date
9/1/2025
Updated
9/2/25, 2:10 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership